digest infographic

Please enter a correct email address

About CurationHealth

When it comes to your health, or the health of someone close to you, it can feel like there’s just too much information out there. At CurationHealth, we get it. We focus on finding relevant and quality news stories about the big health care issues. And we help you make sense of it all.

Exciting news that Saxenda may delay the onset of type 2 diabetes has made a stir this week: we look at the research. New hopes for a cure for proliferative diabetic retinopathy have also been raised. Diabetic peripheral neuropathy is viewed from both ends: when does it start and, in the end, what can be done about it… is a vegan diet the answer? Finally, we look at smart pill boxes that remind us to take our tablets.

It’s been a bad week for those using SGLT2 inhibitors: we look at a recent health warning in the US. Back in the UK, sugar and obesity are in the headlines as the battle against “added sugar” in soft drinks begins. The role of different metabolisms on weight loss is defined – do you have a “thrifty” or “spendthrift” metabolism? A new stocking technology may help “the diabetic foot” and finally we muse on diabetes and the mind: why are we more prone to both dementia and depression?

The increase in strokes amongst younger people hit the headlines this week; we analyse the data and learn how diabetic retinopathy might put you at a higher risk and what’s to be done about this. The relative value of weight loss, exercise and reducing calorie intake to prevent type 2 diabetes have been clarified – all three together is best. Reassurance over the safety of gliptins is welcomed and, finally, we look at whether “smart plates” are really such a smart concept…

No apologies for prioritising the importance of quitting smoking this week as new research confirms that it is “never too late to quit”. Quitting sugary drinks is also on the lifestyle agenda as research shows it may prevent type 2 diabetes. New genetic research has helped to provide insights into ways to prevent and treat both type 2 diabetes and offers hope for one of its more distressing complications, a diabetic foot ulcer. The underuse of metformin in pre-diabetes raised concerns this week in the USA, but not all experts would agree! Finally, is your insulin pen needle too big for your own good?

In the week that a new muesli-type bar was hailed as a breakthrough in the dietary treatment for type 2 diabetes, we look at the research. What does the media furore around “diet versus exercise” in obesity actually mean for those with type 2 diabetes? Also, there is new hope for those with fatty livers - liraglutide might just become the first ever effective drug treatment. On a less positive note, alarm bells rang on the risk of vitamin B12 deficiency for those on metformin using indigestion remedies. Finally, we look at health professionals’ views on mobile medical apps: most don’t think they will help the doctor-patient relationship…

Metformin is a great drug, but it’s not always so great to take! What can be done to make it better? The value of retinal screening is made plain to see and we look at the link between statin use and the risk of diabetes. Also, might pears and eggs help stave off diabetes and in the future will parts of us glow different colours depending on our blood sugar levels? Finally, we refuse to think of dementia as “type 3 diabetes”.

It’s been a big week for lovers of diabetes guidelines – we give you the edited highlights. The value of exercise in diabetes remains unassailable and this week it’s the liver and penis that reap the benefits – just don’t do it near heavy traffic! Finally, we look at screening for diabetes in adults and marvel at devices that may (or may not!) help you avoid losing your insulin and testing kit.

How important is it, really, to get up off the couch and get active in order to prevent diabetes? We consider the importance of erections to male sexual satisfaction and the problems caused by excessive fat in the liver. Finally we muse on magnesium levels and welcome a new device to monitor glucose levels for two weeks at a time.

In this INSIGHTS we look at the risks of breast cancer with diabetes, whether we actually need to self-monitor blood glucose in type 2 diabetes and why sitting does us all no favours. Also we learn that texts can help us manage diabetes and we preview another new single-pill combination therapy coming to market.

In this INSIGHTs we look at the worrying link between antibiotic use and the risk of developing type 2 diabetes, celebrate the significant benefits of eating whole grains and cereals, and welcome the first preventative device for diabetic foot ulcers. We also preview Glyxambi, a new combination drug, and muse on blood glucose testing technologies.